MedPage Today July 12, 2019
“We’ve waited for decades for this to mature,” said Steven Nissen, MD
In this exclusive MedPage Today video, Steven Nissen, MD, of the Cleveland Clinic, joined us at the recent American College of Cardiology meeting in New Orleans to share his excitement for the potential of continuous glucose monitoring as a method for reducing cardiovascular risk.
Following is a transcript of his remarks:
I’m personally very excited about continuous glucose monitoring, and I’m particularly excited that we’re now seeing the first of a generation of closed-loop systems where there’s actually an adjustment of insulin dosage based upon real-time data with respect to blood glucose. We’ve waited for decades for this to mature and there are several things to think...